Sareko albisteak
Itzuli orri hau
2021-06-28
Basel, 28 June 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Commission (EC) has approved ENSPRYNG ® (satralizumab) for the treatment of adults and adolescents from 12 years of age living with anti-aquaporin-4 antibody (AQP4-IgG) seropositive neuromyelitis optica spectrum disorder (NMOSD), as a monotherapy or in combination with immunosuppressive therapy (IST). ENSPRYNG is the first and only NMO SD treatment that is administered subcutaneously every four weeks, allowing home-dosing after appropriate training.“An NMOSD relapse can be devastating, causing permanent neurological damage and disability that accumulates with subsequent relapses, which is why our goal is to prevent them,” said Prof. Dr. Friedemann Paul, Professor of Clinical Neuroimmunology, Cha...
2021-06-17
Title: What Are the Stages of Muscular Dystrophy?Category: Diseases and ConditionsCreated: 6/17/2021 12:00:00 AMLast Editorial Review: 6/17/2021 12:00:00 AM (Source: MedicineNet Kids Health General)<div id="medworm"><p><b><i>MedWorm Message:</i></b> If you are looking to buy something in the <a href="http://thejanuarysales.com/">January Sales</a> please visit <a href="http://thejanuarysales.com/">TheJanuarySales.com</a> for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.</p></div>
2021-07-19
(University of Alabama at Birmingham) An experimental drug reported in Nature Communications suggests that a " path is clearly achievable " to treat currently untreatable cases of cystic fibrosis disease caused by nonsense mutations. This includes about 11 percent of cystic fibrosis patients, as well as patients with other genetic diseases, including Duchenne muscular dystrophy,β-thalassemia and numerous types of cancers, that are also caused by nonsense mutations. (Source: EurekAlert! - Medicine and Health)
2021-09-07
? (Source: eMedicineHealth.com)<div id="medworm"><p><b><i>MedWorm Message:</i></b> Have you tried our new <a href="https://medworm.com/">medical search engine</a>? More powerful than before. Log on with your social media account. 100% free.</p></div>
2021-07-21
The Brigham is the first birth hospital in the nation to develop a program that offers parents an option to have their newborn screened for Duchenne; through early diagnosis, screening may help families take advantage of therapeutic interventions (Source: BWH News)